Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP264655.RAUnvDcuKVeya4LnRuM6Gx4DWJbuD_quBy7r49W3BSPG0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP264655.RAUnvDcuKVeya4LnRuM6Gx4DWJbuD_quBy7r49W3BSPG0130_assertion type Assertion NP264655.RAUnvDcuKVeya4LnRuM6Gx4DWJbuD_quBy7r49W3BSPG0130_head.
- NP264655.RAUnvDcuKVeya4LnRuM6Gx4DWJbuD_quBy7r49W3BSPG0130_assertion wasGeneratedBy ECO_0000203 NP264655.RAUnvDcuKVeya4LnRuM6Gx4DWJbuD_quBy7r49W3BSPG0130_provenance.
- NP264655.RAUnvDcuKVeya4LnRuM6Gx4DWJbuD_quBy7r49W3BSPG0130_assertion wasDerivedFrom befree-20150227 NP264655.RAUnvDcuKVeya4LnRuM6Gx4DWJbuD_quBy7r49W3BSPG0130_provenance.
- NP264655.RAUnvDcuKVeya4LnRuM6Gx4DWJbuD_quBy7r49W3BSPG0130_assertion SIO_000772 19240170 NP264655.RAUnvDcuKVeya4LnRuM6Gx4DWJbuD_quBy7r49W3BSPG0130_provenance.
- NP264655.RAUnvDcuKVeya4LnRuM6Gx4DWJbuD_quBy7r49W3BSPG0130_assertion evidence source_evidence_literature NP264655.RAUnvDcuKVeya4LnRuM6Gx4DWJbuD_quBy7r49W3BSPG0130_provenance.
- NP264655.RAUnvDcuKVeya4LnRuM6Gx4DWJbuD_quBy7r49W3BSPG0130_assertion description "[In contrast, endogenous Bcl-XL showed no correlation either with cisplatin sensitivity in the cell line panel in vitro, or with risk of recurrence in vivo (hazard ratio, 1.28; 95% confidence interval, 0.39-4.19; P=0.68).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264655.RAUnvDcuKVeya4LnRuM6Gx4DWJbuD_quBy7r49W3BSPG0130_provenance.